We’re thrilled to announce the 15th Left Main & Coronary Bifurcation Summit, CBS15th2023, is taking place on November 30-December 3, 2023. CBS15th2023 is hosted by Nanjing First Hospital, Nanjing Medical University, and Asian Bifurcation Club (ABC). CBS provides a dedicated platform for education and training in left main and bifurcation lesion treatments for global colleagues. For decades, upholding the spirit of Creativity, Breakthrough and Science, CBS is one of the the most open, friendly and dynamic symposiums in China, connecting interventional cardiologists from around the world.

LIVE

Live Broadcast

Watch Live

We’re having domestic and international experts share their experiences and best practices on interventional cardiology in both online meetings and offline activities. More program information, lectures foreshow, and announcements are coming soon. Your attendance would be highly appreciated.

·Professor
Shaoliang Chen

General Chairman

The Left Main & Coronary Bifurcation Summit (CBS) is hosted by Nanjing First Hospital, Nanjing Medical University and the Asian Bifurcation Club (ABC). CBS has been a beacon of Creativity, Breakthroughs, and Science for decades, making it the most welcomi

·Professor
Junjie Zhang

·Professor
Fei Ye

Complex Coronary Artery Intervention Forum

With the advancement of technology and accumulated experience, the field of cardiology has been flourishing. From November 30th to December 3rd, 2023, the 15th Summit on Left Main and Coronary Artery Bifurcation Lesions (CBS2023) will once again present a

·Professor
Fei Ye

Intravascular Imaging and Functional Evaluation

In line with the previous academic design principles, as one of the classic academic forums of CBS, the Intracoronary Imaging and Physiological Assessment Forum of this session will further optimize the academic content by integrating the "Impression" For

·Professor
Hang Zhang

·Professor
Dujiang Xie

Pulmonary Arterial Hypertension Forum

Pulmonary vascular diseases have complex etiology and high mortality and disability rates. The establishment of the Pulmonary Vascular Center in National Standardized Cardiovascular Specialty Centers (CDQI) aims to comprehensively improve the diagnosis an

·Professor
Junjie Zhang

·Professor
Ling Zhou

Structural Heart Disease Intervention Forum

The development of interventional treatment for structural heart valve diseases has been advancing rapidly. Over the past two decades, from initial breakthroughs to vigorous development, procedures such as transcatheter aortic valve replacement (TAVR), tr

·Professor
Zuoying Hu

·Professor
Fengfu Zhang

Arrhythmia Forum

CBS2023, rooted in practice and embracing innovation, features multiple forums including "Complex Coronary Artery Disease Intervention Techniques, Intracoronary Imaging, Pulmonary Arterial Hypertension, Structural Heart Disease Intervention, Arrhythmia, H

·Professor
Linlin Zhu

Hypertension Forum

The Hypertension Forum at CBS2023 will focus on the theme of "Achieving Blood Pressure Control, Promoting Public Health." It will closely follow the forefront of hypertension prevention and treatment and showcase the latest research findings. The forum wi

·Professor
Juan Zhang

Heart Failure Forum

Heart failure is a common and extremely severe end-stage cardiovascular disease that affects over 60 million people worldwide. Currently, there are over 10 million heart failure patients in China alone, making it a significant health concern. Heart failur

·Professor
Zhen Ge

Clinical Research Forum

The Clinical Research Forum is a special section of CBS aimed at improving the quality of clinical research in China, enhancing the level of evidence-based medicine, and facilitating the emergence of more high-quality original research. Professor Ge Zhen,

·Professor
Junxia Zhang

Basic Science Forum

Basic medical research plays an extremely important role in the development of new technologies and new approaches for disease diagnosis and treatment. In China, significant breakthroughs have been made in cardiovascular-related basic research and its tra

NEWS More

Nanjing First Hospital successfully broadcasted Live Demo to Pakistan

Nanjing First Hospital successfully broadcasted Live Demo to South America

Left main bifurcation PCI: Similarity and difference between DKCRUSH-V vs. EBC Ma...

Great news｜EuroPCR 2020 releases DEFINITION Ⅱ research

The DEFINITION II study is a prospective, international multi-center, randomized controlled trial initiated by Professor Chen Shaoliang. A total of 49 centers participated. The main purpose of the trial was to compare the eefficacy of the dual stent surgery and provisional surgery in patients with complex bifurcation lesions.. The primary endpoint of the study

“Fight the Pandemic Together-CSC is In the Action”——CSC&Malaysia

On March 26th, the team led by the Fellow Yaling Han of the Northern Theater General Hospital of the Chinese Medical Association Cardiovascular Branch (CSC), President Shaoliang Chen from Nanjing First Hospital, and Doctor Junjie Zhang and other team members, together with Professor Guixian Shen and Tiong from Sarawak, Malaysia -Professor Kiam ONG, Professor Alan Fong, Professor Wan Azman Wan Ahmad, Chairman of Malaysian Cardiology Society, and Mr. Guangzhong Cheng, the Chinese Consulate Gen

Pulmonary Artery Denervation-The Chinese Original Technology

On May 3rd, on the eve of the World Pulmonary Hypertension Day, Professor Shaoliang Chen organized an online lecture by well-known domestic experts and practitioners in the field of the Chinese original technology-pulmonary artery denervation. Pulmonary artery denervation (PADN), proposed by Professor Shaoliang Chen, is a new type of minimally invasive intravascular catheter intervention treatment that uses radiofrequency ablation to block the sympathetic nerves in the pulmonary blood vessels, t

“Fight the Pandemic Together-CSC is In the Action”——CSC&Pakistan

On April 19, under the leadership of President Shaoliang Chen, the Chinese Society of Cardiovascular Diseases (CSC) and the Pakistan Interventional Cardiology Society (PSIC) connected in the cloud and successfully held a seminar on “combat with the Covid-19”. At the meeting, Professor Shaoliang Chen conducted in-depth discussions and exchange ideas and experiences with Pakistani experts.

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

The Department of Cardiovascular Medicine, Nanjing First Hospital, under the leadership of the subject leader P...

The Department of Cardiovascular Medicine, Nanjing First Hospital was established in 1958. After decades of hard work by several generations of cardiovascular experts, it has developed into a unity of medicine, teaching and research, with a complete echelon of talents, strong technical force and medical facilities, a characteristic medical center with advanced and superb diagnosis and treatment.

Structural Cardiovascular Disease Symposium

On June 20th, the Department of Cardiology, Nanjing First Hospital and Nanjing Hospital Affiliated of Nanjing Medical University successfully held a collaborative work conference with the theme of "Structural Heart Disease". Junjie Zhang, the executive deputy director of the Department of Cardiology, delivered an opening speech. In his speech, he fully affirmed the fruitful results of the construction of the sub-centers in all aspects of medical education and research in the past year, and since

CBSMD Scientific Library